annual CFF:
$337.06M+$311.08M(+1197.19%)Summary
- As of today (September 18, 2025), CDTX annual cash flow from financing activities is $337.06 million, with the most recent change of +$311.08 million (+1197.19%) on December 31, 2024.
- During the last 3 years, CDTX annual CFF has risen by +$292.46 million (+655.79%).
- CDTX annual CFF is now at all-time high.
Performance
CDTX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$383.38M+$383.31M(+497802.60%)Summary
- As of today (September 18, 2025), CDTX quarterly cash flow from financing activities is $383.38 million, with the most recent change of +$383.31 million (+497802.60%) on June 30, 2025.
- Over the past year, CDTX quarterly CFF has increased by +$144.25 million (+60.32%).
- CDTX quarterly CFF is now at all-time high.
Performance
CDTX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$481.49M+$144.25M(+42.78%)Summary
- As of today (September 18, 2025), CDTX TTM cash flow from financing activities is $481.49 million, with the most recent change of +$144.25 million (+42.78%) on June 30, 2025.
- Over the past year, CDTX TTM CFF has increased by +$242.44 million (+101.42%).
- CDTX TTM CFF is now at all-time high.
Performance
CDTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CDTX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1197.2% | +60.3% | +101.4% |
| 3 y3 years | +655.8% | +10000.0% | +1302.0% |
| 5 y5 years | +2261.5% | +9633.0% | +915.3% |
CDTX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
CDTX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $383.38M(>+9900.0%) | $481.49M(+42.8%) |
| Mar 2025 | - | $77.00K(-99.9%) | $337.23M(+0.1%) |
| Dec 2024 | $337.06M(+1197.2%) | $98.20M(<-9900.0%) | $337.06M(+41.1%) |
| Sep 2024 | - | -$182.00K(-100.1%) | $238.86M(-0.1%) |
| Jun 2024 | - | $239.13M(<-9900.0%) | $239.05M(<-9900.0%) |
| Mar 2024 | - | -$93.00K(-1262.5%) | -$346.00K(-101.3%) |
| Dec 2023 | $25.98M(-2832.3%) | $8000.00(>+9900.0%) | $25.98M(-2.5%) |
| Sep 2023 | - | $0.00(-100.0%) | $26.64M(-0.4%) |
| Jun 2023 | - | -$261.00K(-101.0%) | $26.75M(+3.3%) |
| Mar 2023 | - | $26.24M(+3851.4%) | $25.90M(-2823.1%) |
| Dec 2022 | -$951.00K(-102.1%) | $664.00K(+520.6%) | -$951.00K(-102.7%) |
| Sep 2022 | - | $107.00K(-109.6%) | $35.26M(+2.7%) |
| Jun 2022 | - | -$1.11M(+81.8%) | $34.34M(-5.5%) |
| Mar 2022 | - | -$611.00K(-101.7%) | $36.34M(-18.5%) |
| Dec 2021 | $44.60M(+19.6%) | $36.88M(-4652.5%) | $44.60M(+448.5%) |
| Sep 2021 | - | -$810.00K(-191.3%) | $8.13M(-35.8%) |
| Jun 2021 | - | $887.00K(-88.4%) | $12.66M(-19.4%) |
| Mar 2021 | - | $7.64M(+1769.2%) | $15.71M(-57.8%) |
| Dec 2020 | $37.28M(+161.2%) | $409.00K(-89.0%) | $37.28M(-3.2%) |
| Sep 2020 | - | $3.72M(-5.6%) | $38.51M(-18.8%) |
| Jun 2020 | - | $3.94M(-86.5%) | $47.42M(+9.1%) |
| Mar 2020 | - | $29.21M(+1680.0%) | $43.48M(+204.7%) |
| Dec 2019 | $14.27M | $1.64M(-87.0%) | $14.27M(+13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $12.63M(>+9900.0%) | $12.62M(-703.8%) |
| Jun 2019 | - | $0.00(0.0%) | -$2.09M(-104.2%) |
| Mar 2019 | - | $0.00(-100.0%) | $49.69M(-11.5%) |
| Dec 2018 | $56.15M(+168.9%) | -$12.00K(-99.4%) | $56.15M(-27.1%) |
| Sep 2018 | - | -$2.08M(-104.0%) | $76.98M(-2.6%) |
| Jun 2018 | - | $51.77M(+700.5%) | $79.06M(+189.7%) |
| Mar 2018 | - | $6.47M(-68.9%) | $27.29M(+30.7%) |
| Dec 2017 | $20.88M(-43.7%) | $20.81M(>+9900.0%) | $20.88M(-43.8%) |
| Sep 2017 | - | $3000.00(-40.0%) | $37.16M(+0.2%) |
| Jun 2017 | - | $5000.00(-92.3%) | $37.10M(-0.1%) |
| Mar 2017 | - | $65.00K(-99.8%) | $37.12M(+0.1%) |
| Dec 2016 | $37.09M(-66.8%) | $37.09M(<-9900.0%) | $37.09M(>+9900.0%) |
| Sep 2016 | - | -$57.00K(-328.0%) | $280.00K(-6.4%) |
| Jun 2016 | - | $25.00K(-39.0%) | $299.00K(-99.6%) |
| Mar 2016 | - | $41.00K(-84.9%) | $70.44M(-37.0%) |
| Dec 2015 | $111.81M(+257.1%) | $271.00K(-813.2%) | $111.81M(-0.2%) |
| Sep 2015 | - | -$38.00K(-100.1%) | $112.09M(+0.0%) |
| Jun 2015 | - | $70.17M(+69.4%) | $112.08M(+56.1%) |
| Mar 2015 | - | $41.41M(+7484.4%) | $71.78M(+129.3%) |
| Dec 2014 | $31.31M(+2441.6%) | $546.00K(-1237.5%) | $31.31M(+1.8%) |
| Sep 2014 | - | -$48.00K(-100.2%) | $30.77M(-0.2%) |
| Jun 2014 | - | $29.87M(+3078.1%) | $30.81M(+3178.1%) |
| Mar 2014 | - | $940.00K | $940.00K |
| Dec 2013 | $1.23M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual CFF year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly CFF year-on-year change?
- What is Cidara Therapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM CFF year-on-year change?
What is Cidara Therapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of CDTX is $337.06M
What is the all time high annual CFF for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual cash flow from financing activities is $337.06M
What is Cidara Therapeutics, Inc. annual CFF year-on-year change?
Over the past year, CDTX annual cash flow from financing activities has changed by +$311.08M (+1197.19%)
What is Cidara Therapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of CDTX is $383.38M
What is the all time high quarterly CFF for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $383.38M
What is Cidara Therapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, CDTX quarterly cash flow from financing activities has changed by +$144.25M (+60.32%)
What is Cidara Therapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of CDTX is $481.49M
What is the all time high TTM CFF for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM cash flow from financing activities is $481.49M
What is Cidara Therapeutics, Inc. TTM CFF year-on-year change?
Over the past year, CDTX TTM cash flow from financing activities has changed by +$242.44M (+101.42%)